Concepedia

Christopher G. Thomson

CG

4

Publications

61

Citations

4

H-Index

2016

Active since

Affiliations

Lycera (United States)(Current)

Christopher G. Thomson is an author at Lycera (United States) specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2016–2024

4

Publications

4

Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension

Duncan Shaw, Ferheen Baig, Ian Bruce et al. · Journal of Medicinal Chemistry · 2016 · 23 citations · Full text

, , +13

Discovery of HC-7366: An Orally Bioavailable and Efficacious GCN2 Kinase Activator

Christopher G. Thomson, Thomas D. Aicher, Weiwei Cheng et al. · Journal of Medicinal Chemistry · 2024 · 14 citations · Full text

Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity

Sheng Wang, Sebastian O. Klein, Sylvia Urban et al. · Nature Communications · 2024 · 13 citations · Full text

Development of autotaxin inhibitors: A series of zinc binding triazoles

Christopher G. Thomson, Darren Le Grand, Mark R. Dowling et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 11 citations · Full text

, , +10

Rows per page

1–4 of 4